Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2007 6
2008 8
2009 3
2010 2
2011 3
2012 1
2013 3
2014 3
2015 1
2016 1
2018 1
2019 2
2020 2
2021 18
2022 13
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary adverse events following immune checkpoint inhibitors.
Spagnolo P, Chaudhuri N, Bernardinello N, Karampitsakos T, Sampsonas F, Tzouvelekis A. Spagnolo P, et al. Among authors: sampsonas f. Curr Opin Pulm Med. 2022 Sep 1;28(5):391-398. doi: 10.1097/MCP.0000000000000895. Epub 2022 Jul 16. Curr Opin Pulm Med. 2022. PMID: 35838354 Free PMC article. Review.
Interstitial Lung Diseases and the Impact of Gender.
Karampitsakos T, Papaioannou O, Katsaras M, Sampsonas F, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Clin Chest Med. 2021 Sep;42(3):531-541. doi: 10.1016/j.ccm.2021.04.011. Clin Chest Med. 2021. PMID: 34353457 Review.
Fanconi syndrome-associated interstitial lung disease.
Papaioannou O, Karampitsakos T, Sampsonas F, Tzouvelekis A. Papaioannou O, et al. Among authors: sampsonas f. BMJ Case Rep. 2022 Jul 4;15(7):e249242. doi: 10.1136/bcr-2022-249242. BMJ Case Rep. 2022. PMID: 35787496
Infliximab-induced interstitial lung disease.
Karampitsakos T, Papaioannou O, Sampsonas F, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. BMJ Case Rep. 2021 Oct 13;14(10):e245726. doi: 10.1136/bcr-2021-245726. BMJ Case Rep. 2021. PMID: 34645638 Free PMC article.
Clinical features and outcomes of patients with myositis associated-interstitial lung disease.
Karampitsakos T, Tzilas V, Papaioannou O, Chrysikos S, Vasarmidi E, Juge PA, Vizirianaki S, Bibaki E, Reppa A, Sidiropoulos P, Katsaras M, Sotiropoulou V, Tsiri P, Koulousousa E, Theochari E, Tsirikos G, Christopoulos I, Malakounidou E, Zarkadi E, Sampsonas F, Hillas G, Karageorgas T, Daoussis D, Kalogeropoulou C, Dimakou K, Tzanakis N, Borie R, Dieudé P, Antoniou K, Crestani B, Bouros D, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Front Med (Lausanne). 2023 Jan 9;9:1096203. doi: 10.3389/fmed.2022.1096203. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698813 Free PMC article.
Bronchoscopy-related outbreaks and pseudo-outbreaks: A systematic review.
Kakoullis L, Economidou S, Mehrotra P, Panos G, Karampitsakos T, Stratakos G, Tzouvelekis A, Sampsonas F. Kakoullis L, et al. Among authors: sampsonas f. Infect Control Hosp Epidemiol. 2024 Apr;45(4):509-519. doi: 10.1017/ice.2023.250. Epub 2023 Dec 15. Infect Control Hosp Epidemiol. 2024. PMID: 38099453 Review.
SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts.
Karampitsakos T, Galaris A, Barbayianni I, DeIuliis G, Ahangari F, Sampsonas F, Sotiropoulou V, Aidinis V, Bennett AM, Herazo-Maya JD, Xylourgidis N, Bakakos P, Bouros D, Kaminski N, Tzouvelekis A. Karampitsakos T, et al. Among authors: sampsonas f. Diagnostics (Basel). 2023 Mar 18;13(6):1166. doi: 10.3390/diagnostics13061166. Diagnostics (Basel). 2023. PMID: 36980473 Free PMC article.
70 results